Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenocarcinoma of the Stomach × tesetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Neoplasm Metastasis 2 Melanoma 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Adenocarcinoma of the Stomach 1

Interventions

toripalimab 2 Oxaliplatin 2 tesetaxel 1 indusatumab 1 Trastuzumab 1 S 1 (combination) 1 Leucovorin 1 GC1118 1 Fluorouracil 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01095120 2012-03-15

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Genta Incorporated

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma of the Stomach

Data powered by HemOnc (CC BY 4.0) Colophon ⚡